A phase I clinical trial of low-dose interferon-α-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma

Author： Amato Robert   Khan Muhammad  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.61, Iss.6, 2008-05, pp. : 1069-1073

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A low-dose combination therapy of interleukin-2 and interferon-α is effective for lung metastasis of renal cell carcinoma: a multicenter open study

By Akaza Hideyuki   Tsukamoto Taiji   Onishi Tetsuro   Miki Tsuneharu   Kinouchi Toshiaki   Naito Seiji  

International Journal of Clinical Oncology, Vol. 11, Iss. 6, 2006-12 ,pp. : 434-440

Springer Publishing Company

Access to resources Recommend Favorite

A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-α2b in patients with solid tumors

By Schneider Bryan   Fukunaga Anna   Murry Daryl   Yoder Christy   Fife Karen   Foster Anne   Rosenberg Leslie   Kelich Stephanie   Li Lang   Sweeney Christopher  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 2, 2007-02 ,pp. : 261-268

Springer Publishing Company

Access to resources Recommend Favorite

A Randomized Phase 2 Trial of Bevacizumab with or without Daily Low-Dose Interferon Alfa-2b in Metastatic Malignant Melanoma

By Varker Kimberly   Biber Jennifer   Kefauver Cheryl   Jensen Rhonda   Lehman Amy   Young Donn   Wu Haifeng   Lesinski Gregory   Kendra Kari   Chen Helen   Walker Michael   Carson III William  

Annals of Surgical Oncology, Vol. 14, Iss. 8, 2007-08 ,pp. : 2367-2376

Springer Publishing Company

Access to resources Recommend Favorite

A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma

By Park Byeong-Bae   Park Joon   Lee Hyo   Lee Jeeyun   Choi Dong   Choi Seong-Ho   Heo Jin   Lee Jong   Lee Kyu   Lim Do   Park Young   Lim Ho-Yeong   Kang Won   Park Keunchil  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 489-494

Springer Publishing Company

Access to resources Recommend Favorite

Quality of life in patients with metastatic renal cell carcinoma participating in a phase I trial of an autologous tumor-derived vaccine

By Cohen L.   de Moor C.   Parker P.A.   Amato R.J.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 3, 2002-05 ,pp. : 119-124

Elsevier

Access to resources Recommend Favorite